Correction
Published on 25 Oct 2024
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder
in Respiratory Pharmacology
- 972 views
- 1 citation















